DiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Clinical Trials as TopicRandomized Controlled Trials as TopicClinical Trials Data Monitoring CommitteesTreatment OutcomeClinical Trials, Phase III as TopicCost-Benefit AnalysisDrug IndustryModels, EconomicDrug CostsData Interpretation, StatisticalResearch DesignEthics CommitteesUnited StatesDrug Therapy, CombinationCommittee MembershipAdvisory CommitteesTime FactorsEthics Committees, ResearchRisk AssessmentNeoplasmsSeverity of Illness IndexAntineoplastic AgentsProfessional Staff CommitteesRisk FactorsEthics Committees, ClinicalDouble-Blind MethodMulticenter Studies as TopicEthical ReviewClinical Trials, Phase II as TopicPharmacy and Therapeutics CommitteeAnimal Care CommitteesClinical Trials, Phase I as TopicEvidence-Based MedicinePatient SelectionControlled Clinical Trials as TopicPlacebosQuality-Adjusted Life YearsEndpoint DeterminationAccess to InformationProspective StudiesFollow-Up StudiesPractice Guidelines as TopicOutcome Assessment (Health Care)Clinical ProtocolsReproducibility of ResultsSurvival AnalysisDrug Administration ScheduleQuality of LifeSocieties, MedicalStrokeMeta-Analysis as TopicInformation DisseminationPatient DropoutsResearch SubjectsQuestionnairesHealth Care CostsData CollectionHuman ExperimentationClinical Trials, Phase IV as TopicGreat BritainEuropeDecision Support TechniquesSingle-Blind MethodBreast NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsPrognosisBias (Epidemiology)Retrospective StudiesDose-Response Relationship, DrugBiomedical ResearchRecurrenceAntibodies, Monoclonal, HumanizedEthics, ResearchInformed ConsentEarly Termination of Clinical TrialsGuidelines as TopicDisease ProgressionAntirheumatic AgentsCardiovascular DiseasesModels, StatisticalChemotherapy, AdjuvantEthics, MedicalAcute DiseaseHIV InfectionsSample SizePlatelet Aggregation InhibitorsEthics ConsultationPilot ProjectsFibrinolytic AgentsAnti-Bacterial AgentsTherapeutic Human ExperimentationAge FactorsAntibodies, MonoclonalDatabases, FactualCombined Modality TherapyAnticoagulantsSensitivity and SpecificityAntihypertensive AgentsIncidenceMedical Oncology

Systematic review of safety in paediatric drug trials published in 2007. (33/43)

 (+info)

Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study. (34/43)

 (+info)

Moving a randomized clinical trial into an observational cohort. (35/43)

 (+info)

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. (36/43)

 (+info)

The future of monitoring in clinical research - a holistic approach: linking risk-based monitoring with quality management principles. (37/43)

 (+info)

The role of the Data and Safety Monitoring Board in a clinical trial: the CRISIS study. (38/43)

 (+info)

When enough is enough: how the decision was made to stop the FEAST trial: data and safety monitoring in an African trial of Fluid Expansion As Supportive Therapy (FEAST) for critically ill children. (39/43)

 (+info)

Six pairs of things to celebrate on International Clinical Trials Day. (40/43)

 (+info)